Ausbiz Capital is now SureStone Capital. Same team, same ABN and AFS authorisations.

ASX: MVFMonash IVF Group LimitedHealth Care

Monash IVF Sees FY27 Underlying NPAT Materially Below FY26

Monash IVF expects underlying FY27 NPAT to be materially below FY26 and consensus after the Australian stimulated-cycle market contracted 3.2% in Q1 FY27.

By Digifin Pty Ltd · About this coverage

Key Points

  • Australian stimulated-cycle market contracted by 3.2% in Q1 FY27 relative to Q4 FY26
  • 12 month rolling market share of 19.4%, broadly in line with 30 June 2026
  • Transformation program targeted to deliver $8-11 million annualised pre-tax savings
  • No quantitative FY27 earnings guidance; further update due with half year results
Monash IVF Group Limited (ASX:MVF)

About Monash IVF (ASX:MVF)

Monash IVF Group Limited is an ASX-listed provider of assisted reproductive services headquartered in Melbourne. It operates fertility clinics, day hospitals, genetics and diagnostic laboratories and women's imaging services in Australia, and also has clinics in Malaysia and Singapore. Its services include in vitro fertilisation, donor programs and preimplantation genetic testing.

Monash IVF (ASX:MVF) released this trading update to warn that it expects underlying FY27 NPAT to be materially below FY26 and current analyst consensus estimates, citing cost pressures and softer volumes.

Relative to Q4 FY26, the Australian stimulated-cycle market contracted by 3.2% in Q1 FY27. The company's 12 month rolling market share of 19.4% was broadly in line with its share at 30 June 2026, with share lost in South Australia due to new local competitive pressures. It reports fixed cost increases above inflation, largely in occupancy, wages and insurance premiums, above inflation price increases from some key suppliers, and commissioning losses on new capacity in Queensland day surgery and WA ultrasound. Its Brisbane operations were temporarily closed for approximately one month in July 2026 during the move to a new facility. The structural productivity transformation program remains targeted to deliver $8-11 million annualised pre-tax savings, but earnings benefits are now expected over a longer period than previously anticipated. Depreciation and interest expenses are expected to be higher than FY26. The company says trading in October and November delivered improved earnings performance against Q1 FY27.

The outlook assumes market activity does not improve in H2 FY27. The Board does not consider there is a sufficiently reliable basis for quantitative FY27 earnings guidance, and the figures are unaudited. A further update is planned with the half year results.

Back to all ASX Company News

Source: Monash IVF Group Limited (ASX:MVF), 20 November 2026. Summary content supplied by Digifin Pty Ltd.

News summary only, not financial advice. It does not consider your objectives, financial situation or needs.

Friday, 20 November 2026

Also summarised today

All ASX Company News
ASX: ASGConsumer Discretionary

Autosports Group Sees H1 FY27 Revenue In Line With Plan

Autosports Group expects H1 FY27 revenue of $1.7 billion to $1.75 billion, with inventory cuts weighing on gross margin before an expected H2 margin uplift.

20 Nov, 8:26 am AEDT
ASX: DURIndustrials

Duratec Wins Santos, Home Affairs and Defence Fuel Contracts

Duratec has won three contracts worth over $200m combined, led by a four-year Santos maintenance deal, plus Yongah Hill and RAAF Base Learmonth fuel works.

20 Nov, 8:21 am AEDT
ASX: EBRHealth Care

CMS Proposes National Medicare Coverage for EBR WiSE System

CMS has proposed national Medicare coverage for EBR Systems' WiSE System under Coverage with Evidence Development, with a final decision due by February 2027.

20 Nov, 8:50 am AEDT
ASX: KOAConsumer Discretionary

Koala Written Sales Up 35.0% in First 17 Weeks of FY27

The Koala Company says written sales grew 35.0% in constant currency in the 17 weeks to 31 October, with all markets in growth, before its peak trading period.

20 Nov, 9:04 am AEDT
ASX: MC2Materials

Marimaca Reports 102m of 1.00% Cu at Pampa Medina

Marimaca Copper reported Pampa Medina assays including 102m of 1.00% Cu and 5.1g/t Ag in SPRD-21 as central zone drilling nears completion in northern Chile.

20 Nov, 8:37 am AEDT
ASX: NXTInformation Technology

NEXTDC Upgrades FY27 Revenue and Underlying EBITDA Guidance

NEXTDC raised FY27 guidance to net revenue of A$485m to A$500m and Underlying EBITDA of A$260m to A$275m, and reaffirmed capex of A$4,500m to A$5,000m.

20 Nov, 8:24 am AEDT
ASX: ORNMaterials

Orion Receives US$6.7M First Glencore Prepayment Drawdown

Orion Minerals has received a US$6.7 million first drawdown under its Glencore prepayment, allowing early works at the Prieska Copper Zinc Mine Uppers Mine.

20 Nov, 9:04 am AEDT
ASX: PMEHealth Care

Pro Medicus Signs 10-Year A$128M NYC Health + Hospitals Deal

Pro Medicus subsidiary Visage Imaging has signed a 10-year, A$128M contract to roll out its cloud-based Visage 7 platform across NYC Health + Hospitals.

20 Nov, 8:27 am AEDT
ASX: SGMMaterials

Sims Lifts 1H FY27 Lifecycle Services EBIT Guidance

Sims expects 1H FY27 Group Underlying EBIT of $270 million to $285 million after lifting Sims Lifecycle Services guidance to $120 million to $130 million.

20 Nov, 8:19 am AEDT

Announcement summaries are published each trading day. General advice only.

Copyright © 2026 SureStone Capital